the predictive power of the breast cancer index (h/i) biomarker-sabcs 2022
Published 1 year ago • 752 plays • Length 20:25Download video MP4
Download video MP3
Similar videos
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
1:12
inclusion of breast cancer index in guidelines
-
5:04
standardizing extended endocrine therapy recommendations
-
0:31
breast cancer index ideal study
-
2:57
key data from the san antonio breast cancer symposium (sabcs) 2022
-
37:59
dr. charles perou | distinguished lectureship in breast cancer research | sabcs 2022
-
29:57
dr. prudence francis | premenopausal er breast cancer: past, present, future | sabcs 2022
-
9:53
fibrosis biomarker: can it predict survival rates in her2-negative breast cancer?
-
3:16
what is breast cancer index?
-
16:19
breast cancer index, extended endocrine therapy | elizabeth ott, pa | 2022 west oncology app updates
-
0:51
breast cancer index is the modern tool to select patients for extended endocrine therapy
-
5:27
breast cancer index patient testimonials
-
0:35
how does breast cancer index help with patient selection for extended endocrine therapy?
-
10:35
sabcs 2022 - exact sciences announces data supporting future of breast cancer care continuum
-
4:07
new advances in hormonal therapies for er-positive breast cancer
-
2:19
prognosis for breast cancer
-
0:45
do clinical and pathological factors preduct extended endocrine benefit
-
2:10
what is the prognosis of breast cancer? | norton cancer institute
-
1:06
ebcc 8: endocrine management of breast cancer and advanced breast cancer